Stocks and Investing
Stocks and Investing
Thu, September 8, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, September 7, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jailendra Singh Initiated (TDOC) at Hold and Held Target at $35 on, Sep 7th, 2022
Jailendra Singh of Truist Securities, Initiated "Teladoc Health, Inc." (TDOC) at Hold and Held Target at $35 on, Sep 7th, 2022.
Jailendra has made no other calls on TDOC in the last 4 months.
There are 11 other peers that have a rating on TDOC. Out of the 11 peers that are also analyzing TDOC, 7 agree with Jailendra's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Charles Rhyee of "Cowen & Co." Downgraded from Buy to Hold and Decreased Target to $34 on, Tuesday, August 2nd, 2022
- Ravi Misra of "Berenberg" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, August 2nd, 2022
- Cindy Motz of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $36 on, Thursday, July 28th, 2022
- Ryan MacDonald of "Needham" Downgraded from Strong Buy to Hold on, Thursday, July 28th, 2022
- Stephanie Davis Demko of "SVB Leerink" Maintained at Hold with Decreased Target to $34 on, Thursday, July 28th, 2022
- Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $40 on, Thursday, July 28th, 2022
- David Grossman of "Stifel" Maintained at Hold with Decreased Target to $36 on, Wednesday, June 29th, 2022
These are the ratings of the 4 analyists that currently disagree with Jailendra
- Sandy Draper of "Guggenheim" Downgraded from Hold to Strong Sell and Held Target at $25 on, Wednesday, August 17th, 2022
- Robert Simmons of "DA Davidson" Initiated at Strong Buy and Held Target at $45 on, Friday, August 12th, 2022
- Jessica Tassan of "Piper Sandler" Maintained at Buy with Decreased Target to $40 on, Thursday, July 28th, 2022
- Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $55 on, Thursday, July 28th, 2022
Contributing Sources